Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09QBG
|
||||
Former ID |
DNCL001859
|
||||
Drug Name |
Cangrelor
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
The Medicines Company
|
||||
Structure |
Download2D MOL |
||||
Formula |
C17H25Cl2F3N5O12P3S2
|
||||
InChI |
InChI=1S/C17H25Cl2F3N5O12P3S2/c1-43-5-3-23-12-9-13(26-15(25-12)44-4-2-16(20,21)22)27(7-24-9)14-11(29)10(28)8(38-14)6-37-42(35,36)39-41(33,34)17(18,19)40(30,31)32/h7-8,10-11,14,28-29H,2-6H2,1H3,(H,33,34)(H,35,36)(H,23,25,26)(H2,30,31,32)/t8-,10-,11-,14-/m1/s1
|
||||
InChIKey |
PAEBIVWUMLRPSK-IDTAVKCVSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | P2Y purinoceptor 12 | Target Info | Antagonist | [543771] | |
KEGG Pathway | Platelet activation | ||||
References | |||||
Ref 521896 | ClinicalTrials.gov (NCT00385138) Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.. U.S. National Institutes of Health. | ||||
Ref 539125 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1776). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.